PMC:7309518 / 303-636
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 237-245 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
| T2 | 251-256 | Body_part | denotes | nerve | http://purl.org/sig/ont/fma/fma65132 |
| T3 | 257-268 | Body_part | denotes | glycolipids | http://purl.org/sig/ont/fma/fma82780 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 251-256 | Body_part | denotes | nerve | http://purl.obolibrary.org/obo/UBERON_0001021 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T10 | 94-97 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
| T11 | 116-124 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T12 | 288-296 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 251-256 | http://purl.obolibrary.org/obo/UBERON_0001021 | denotes | nerve |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 237-245 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T2 | 257-268 | Chemical | denotes | glycolipids | http://purl.obolibrary.org/obo/CHEBI_33563 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 15 | 116-124 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 16 | 225-230 | Disease | denotes | COVID | MESH:C000657245 |
| 17 | 288-296 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T7 | 79-86 | Sentence | denotes | Methods |
| T8 | 87-269 | Sentence | denotes | Eleven GBS cases in four key COVID-19 hotspots are discussed regarding presenting symptoms, response to therapies and cross-reactivity of COVID spike proteins with nerve glycolipids. |